Neil E. Kay

560 papers receiving 24.1k citations

Neil E. Kay's Hit Papers

Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial 2022 · 175 citations
1750+10+20Years since publication50010001.5k

Peers

Neil E. Kay
Comparison fields: 5 of 161
  • Genetics 15.5k
  • Pathology and Forensic Medicine 10.3k
  • Immunology 7.9k
  • Hematology 4.0k
  • Oncology 4.5k
Replace Maher X. Albitar with:
Maher X. Albitar United States
Anas Younes United States
Zeev Estrov United States
Steven T. Rosen United States
Moshe Talpaz United States
Sergio Amadori Italy
Allen P. Kaplan United States
Giuseppe Basso Italy
Rene Toes Netherlands
Edward Clark Keystone Canada
Neil E. Kay relative to Maher X. Albitar United States Maher X. Albitar's profile →
Citations per field
00.5×2×3×3.9×
Maher X. Albitar · 1×
Citations per year

Countries citing papers authored by Neil E. Kay

Since Specialization
Citations

This map shows the geographic impact of Neil E. Kay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil E. Kay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil E. Kay more than expected).

Fields of papers citing papers by Neil E. Kay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil E. Kay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil E. Kay. The network helps show where Neil E. Kay may publish in the future.

Co-authors

The 25 scholars most cited alongside Neil E. Kay, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Neil E. Kay Line = papers co-authored together Neil E. Kay links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 579 papers — load more, or switch the sort, to bring in the rest.

#Work
1
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Hit paper breakdown →
19961603
2
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
Hit paper breakdown →
20141374
3
Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia
Hit paper breakdown →
2019608
4
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts
Hit paper breakdown →
2018520
5
Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial
Hit paper breakdown →
2021485
6 2017362
7 1988355
8 2005315
9 2009280
10 2002278
11 2008266
12 2006244
13 2014221
14 2006209
15 2009204
16 2003199
17 2002198
18 2013194
19 2013189
20 2003184

About Neil E. Kay

Neil E. Kay is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Oncology, having authored 579 papers that have together received 24.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (466 papers), Lymphoma Diagnosis and Treatment (238 papers), Immunodeficiency and Autoimmune Disorders (150 papers), Monoclonal and Polyclonal Antibodies Research (42 papers), Acute Lymphoblastic Leukemia research (38 papers), Advanced Breast Cancer Therapies (36 papers), Glycosylation and Glycoproteins Research (35 papers) and Chronic Myeloid Leukemia Treatments (32 papers). The work is most often cited by research in Genetics (15.5k citations), Pathology and Forensic Medicine (10.3k citations), Immunology (7.9k citations), Hematology (4.0k citations) and Oncology (4.5k citations). Neil E. Kay has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Tait D. Shanafelt, Diane F. Jelinek, Timothy G. Call, Clive S. Zent, Susan L. Slager, Michael R. Grever, Nancy D. Bone, Susan Marie Schwager, Cheson Bd and J M Bennett. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, American Journal of Hematology and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact